Article
A Novel STAT3 Gain-of-Function Mutation in Fatal Infancy-Onset Interstitial Lung Disease.
Frontiers in immunology - 1 Jan 2022
Deng Mengyue, Li Yue, Li Yulu, Mao Xiaolan, Ke Han, Liang Weiling, Lei Xiaoguang, Lau Yu-Lung, Mao Huawei
Abstract excerpt
Signal transducer and activator of transcription 3 (STAT3) gain-of-function (GOF) mutations cause early-onset immune dysregulation syndrome, characterized by multi-organ autoimmunity and lymphoproliferation. Of them, interstitial lung disease (ILD) usually develops after the involvement of other organs, and the onset time is childhood and beyond rather than infancy. Here, we reported a patient who presented with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
